日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Programmed death ligand-1 PET imaging in patients with melanoma: a pilot study

黑色素瘤患者程序性死亡配体-1 PET成像:一项初步研究

Pandit-Taskar, Neeta; Mauguen, Audrey; Frosina, Denise; Jungbluth, Achim; Busam, Klaus J; Lyashchenko, Serge; Schwartz, Jazmin; Momtaz, Parisa; Warner, Allison Betof; Smithy, James W; Shoushtari, Alexander N; Callahan, Margaret K; Chapman, Paul B; Postow, Michael A

A phase II randomized trial of talimogene laherparepvec oncolytic immunotherapy with or without radiotherapy for patients with cutaneous metastases from solid tumors

一项针对实体瘤皮肤转移患者的talimogene laherparepvec溶瘤免疫疗法(联合或不联合放射治疗)的II期随机试验

Barker, Christopher A; D'Angelo, Sandra P; Wasilewski, Gloria; Steckler, Alexa M; Lian, Ming; Zhang, Zhigang; Chapman, Paul B; Shoushtari, Alexander N; Ariyan, Charlotte E

Decision-Making and Health-Related Quality of Life in Patients with Melanoma Considering Adjuvant Immunotherapy

黑色素瘤患者考虑辅助免疫疗法时的决策和健康相关生活质量

Atkinson, Thomas M; Hay, Jennifer L; Young Kim, Soo; Schofield, Elizabeth; Postow, Michael A; Momtaz, Parisa; Warner, Allison Betof; Shoushtari, Alexander N; Callahan, Margaret K; Wolchok, Jedd D; Li, Yuelin; Chapman, Paul B

Phase Ib Trial of Phenformin in Patients with V600-mutated Melanoma Receiving Dabrafenib and Trametinib

苯乙双胍治疗接受达拉非尼和曲美替尼治疗的V600突变黑色素瘤患者的Ib期试验

Chapman, Paul B; Klang, Mark; Postow, Michael A; Shoushtari, Alexander Noor; Sullivan, Ryan J; Wolchok, Jedd D; Merghoub, Taha; Budhu, Sadna; Wong, Phillip; Callahan, Margaret K; Zheng, Bin; Zippin, Jonathan

Beyond the 5-year milestone: Long-term survivorship of melanoma patients treated off-trial with anti-PD-1

超越5年里程碑:接受抗PD-1治疗的非试验性黑色素瘤患者的长期生存情况

Loo, Kimberly; Kalvin, Hannah L; Panageas, Katherine S; Callahan, Margaret K; Chapman, Paul B; Momtaz, Parisa; Shoushtari, Alexander N; Wolchok, Jedd D; Postow, Michael A; Warner, Allison Betof

Adaptive Dosing of Nivolumab + Ipilimumab Immunotherapy Based Upon Early, Interim Radiographic Assessment in Advanced Melanoma (The ADAPT-IT Study)

基于早期、中期放射学评估的纳武利尤单抗+伊匹木单抗免疫疗法在晚期黑色素瘤中的适应性给药(ADAPT-IT 研究)

Postow, Michael A; Goldman, Debra A; Shoushtari, Alexander N; Betof Warner, Allison; Callahan, Margaret K; Momtaz, Parisa; Smithy, James W; Naito, Ellesa; Cugliari, Marina K; Raber, Vladislav; Eton, Omar; Nair, Suresh G; Panageas, Katherine S; Wolchok, Jedd D; Chapman, Paul B

PD-1 or PD-L1 Blockade Adds Little to Combination of BRAF and MEK Inhibition in the Treatment of BRAF V600-Mutated Melanoma

在BRAF V600突变型黑色素瘤的治疗中,PD-1或PD-L1阻断对BRAF和MEK抑制剂联合治疗的疗效提升有限。

Callahan, Margaret K; Chapman, Paul B

Targeting Tumor-Rejection Antigens in Melanoma With Tumor-Infiltrating Lymphocytes

利用肿瘤浸润淋巴细胞靶向黑色素瘤中的肿瘤排斥抗原

Chapman, Paul B

Risks and benefits of reinduction ipilimumab/nivolumab in melanoma patients previously treated with ipilimumab/nivolumab

既往接受过伊匹木单抗/纳武单抗治疗的黑色素瘤患者再次接受伊匹木单抗/纳武单抗治疗的风险和获益

Chapman, Paul B; Jayaprakasam, Vetri Sudar; Panageas, Katherine S; Callahan, Margaret; Postow, Michael A; Shoushtari, Alexander N; Wolchok, Jedd D; Betof Warner, Allison

The Genetic Evolution of Treatment-Resistant Cutaneous, Acral, and Uveal Melanomas

难治性皮肤、肢端和葡萄膜黑色素瘤的遗传演变

Makohon-Moore, Alvin P; Lipson, Evan J; Hooper, Jody E; Zucker, Amanda; Hong, Jungeui; Bielski, Craig M; Hayashi, Akimasa; Tokheim, Collin; Baez, Priscilla; Kappagantula, Rajya; Kohutek, Zachary; Makarov, Vladimir; Riaz, Nadeem; Postow, Michael A; Chapman, Paul B; Karchin, Rachel; Socci, Nicholas D; Solit, David B; Chan, Timothy A; Taylor, Barry S; Topalian, Suzanne L; Iacobuzio-Donahue, Christine A